Keith Michael Gottesdiener - Net Worth and Insider Trading

Keith Michael Gottesdiener Net Worth

The estimated net worth of Keith Michael Gottesdiener is at least $26 Million dollars as of 2024-07-15. Keith Michael Gottesdiener is the CEO & President of Rhythm Pharmaceuticals Inc and owns about 506,342 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $26 Million. Keith Michael Gottesdiener is also the Director of Intercept Pharmaceuticals Inc and owns about 5,001 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $95,019. Details can be seen in Keith Michael Gottesdiener's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith Michael Gottesdiener has not made any transactions after 2019-03-18 and currently still holds the listed stock(s).

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Keith Michael Gottesdiener

To

Keith Michael Gottesdiener Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Keith Michael Gottesdiener owns 3 companies in total, including Intercept Pharmaceuticals Inc (ICPT) , Rhythm Pharmaceuticals Inc (RYTM) , and Prime Medicine Inc (PRME) .

Click here to see the complete history of Keith Michael Gottesdiener’s form 4 insider trades.

Insider Ownership Summary of Keith Michael Gottesdiener

Ticker Comapny Transaction Date Type of Owner
ICPT Intercept Pharmaceuticals Inc 2020-05-28 director
RYTM Rhythm Pharmaceuticals Inc 2019-03-18 director & CEO and President
PRME Prime Medicine Inc 2022-10-19 director & See Remarks

Keith Michael Gottesdiener Latest Holdings Summary

Keith Michael Gottesdiener currently owns a total of 2 stocks. Among these stocks, Keith Michael Gottesdiener owns 506,342 shares of Rhythm Pharmaceuticals Inc (RYTM) as of March 18, 2019, with a value of $26 Million and a weighting of 99.64%. Keith Michael Gottesdiener also owns 5,001 shares of Intercept Pharmaceuticals Inc (ICPT) as of April 9, 2018, with a value of $95,019 and a weighting of 0.36%.

Latest Holdings of Keith Michael Gottesdiener

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RYTM Rhythm Pharmaceuticals Inc 2019-03-18 506,342 51.90 26,279,150
ICPT Intercept Pharmaceuticals Inc 2018-04-09 5,001 19.00 95,019

Holding Weightings of Keith Michael Gottesdiener


Keith Michael Gottesdiener Form 4 Trading Tracker

According to the SEC Form 4 filings, Keith Michael Gottesdiener has made a total of 0 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 10,290 shares on March 18, 2019, which brought Keith Michael Gottesdiener around $309,626.

According to the SEC Form 4 filings, Keith Michael Gottesdiener has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the acquisition of 1,171 shares on April 9, 2018, which cost Keith Michael Gottesdiener around $74,944.

Insider Trading History of Keith Michael Gottesdiener

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Keith Michael Gottesdiener Trading Performance

GuruFocus tracks the stock performance after each of Keith Michael Gottesdiener's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith Michael Gottesdiener is 36.02%. GuruFocus also compares Keith Michael Gottesdiener's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith Michael Gottesdiener within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Keith Michael Gottesdiener's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Keith Michael Gottesdiener

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 0.75 LIMIT LIMIT LIMIT LIMIT LIMIT

Keith Michael Gottesdiener Ownership Network

Ownership Network List of Keith Michael Gottesdiener

No Data

Ownership Network Relation of Keith Michael Gottesdiener

Insider Network Chart

Keith Michael Gottesdiener Owned Company Details

What does Intercept Pharmaceuticals Inc do?

Who are the key executives at Intercept Pharmaceuticals Inc?

Keith Michael Gottesdiener is the director of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .

Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intercept Pharmaceuticals Inc Insider Transactions

No Available Data

Keith Michael Gottesdiener Mailing Address

Above is the net worth, insider trading, and ownership report for Keith Michael Gottesdiener. You might contact Keith Michael Gottesdiener via mailing address: 900 Fifth Avenue, #8c, New York Ny 10021.

Discussions on Keith Michael Gottesdiener

No discussions yet.